Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Other Non-Current Assets (2020)

Lexaria Bioscience's Other Non-Current Assets history spans 1 years, with the latest figure at $49333.0 for Q4 2020.

  • Quarterly results put Other Non-Current Assets at $49333.0 for Q4 2020, changed N/A from a year ago — trailing twelve months through Nov 2020 was $49333.0 (changed N/A YoY), and the annual figure for FY2020 was $105250.0, changed.
  • Other Non-Current Assets for Q4 2020 was $49333.0 at Lexaria Bioscience, down from $105250.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $105250.0 in Q2 2020 to a low of $49333.0 in Q4 2020.